Condition
Advanced Malignant Pleural Mesothelioma
Estimated Enrollment: 100
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
Study ID Numbers: NGR019|2010-023614-31
Study First Received: May 19, 2011
Last Updated: May 27, 2016
Estimated Primary Completion Date: December 2016
Primary Outcome Measures:
Progression-Free Survival (PFS)|Overall survival (OS)|Tumor response|Safety and Toxicity according to NCI-CTCAE criteria(version 4.03)|Quality of life (QoL) according to Lung Cancer Symptom Scale
Sponsors and Collaborators:
MolMed S.p.A.
Website Link: https://ClinicalTrials.gov/show/NCT01358084
